VAN ECK ASSOCIATES CORP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$22,420
+16.4%
220,109
+15.3%
0.05%
+16.7%
Q2 2023$19,259
-2.5%
190,857
-11.1%
0.04%
-6.7%
Q1 2023$19,759
-31.4%
214,777
-32.4%
0.04%
-39.2%
Q4 2022$28,818
-99.9%
317,655
-6.6%
0.07%
-3.9%
Q3 2022$25,860,000
-10.9%
340,215
-0.9%
0.08%0.0%
Q2 2022$29,011,000
+50.6%
343,204
+56.3%
0.08%
+92.5%
Q1 2022$19,266,000
+1.2%
219,555
+0.9%
0.04%
-9.1%
Q4 2021$19,038,000
+22.7%
217,655
+14.7%
0.04%
+12.8%
Q3 2021$15,520,000
+32.8%
189,781
+48.1%
0.04%
+39.3%
Q2 2021$11,689,000
-0.6%
128,110
-6.9%
0.03%
-12.5%
Q1 2021$11,763,000
-9.4%
137,608
+0.1%
0.03%
-15.8%
Q4 2020$12,982,000
-44.3%
137,473
-48.7%
0.04%
+2.7%
Q3 2020$23,288,000
-0.5%
267,812
-0.1%
0.04%
-9.8%
Q2 2020$23,416,000
+150.8%
268,108
+136.8%
0.04%
-12.8%
Q1 2020$9,336,000
-7.2%
113,237
+6.6%
0.05%
+20.5%
Q4 2019$10,057,000
+42.7%
106,206
+30.9%
0.04%
+18.2%
Q3 2019$7,050,000
-20.0%
81,129
-16.0%
0.03%
-21.4%
Q2 2019$8,817,000
-11.5%
96,556
-6.9%
0.04%
-14.3%
Q1 2019$9,968,000
-17.9%
103,678
-26.7%
0.05%
-19.7%
Q4 2018$12,137,000
-11.8%
141,437
-11.4%
0.06%
-9.0%
Q3 2018$13,759,000
-1.9%
159,691
-14.0%
0.07%
+1.5%
Q2 2018$14,025,000
+13.4%
185,664
+21.4%
0.07%
+8.2%
Q1 2018$12,370,000
-9.0%
152,995
-5.5%
0.06%
-9.0%
Q4 2017$13,587,000
-3.4%
161,832
-1.2%
0.07%
-6.9%
Q3 2017$14,065,000
-22.1%
163,831
-24.2%
0.07%
-27.3%
Q2 2017$18,053,000
-7.7%
216,278
-17.9%
0.10%
+15.1%
Q1 2017$19,568,000
-5.3%
263,466
-7.2%
0.09%
-16.5%
Q4 2016$20,674,000
+75.9%
283,834
+90.6%
0.10%
+87.3%
Q3 2016$11,756,000
-12.2%
148,884
-8.2%
0.06%
-20.3%
Q2 2016$13,388,000
+3.3%
162,256
-9.3%
0.07%
-20.7%
Q1 2016$12,961,000
-50.2%
178,920
-40.8%
0.09%
-57.8%
Q4 2015$26,004,000
+4.6%
302,231
+11.8%
0.21%
+7.9%
Q3 2015$24,849,000
-14.4%
270,329
-8.4%
0.19%
+11.0%
Q2 2015$29,013,000
-8.1%
295,031
-7.8%
0.17%
-5.5%
Q1 2015$31,571,000
+7.8%
320,157
+1.3%
0.18%0.0%
Q4 2014$29,276,000
-27.7%
315,947
-26.6%
0.18%
-15.3%
Q3 2014$40,512,000
+16.4%
430,386
+11.9%
0.22%
+33.5%
Q2 2014$34,811,000
+26.0%
384,524
+18.4%
0.16%
+17.5%
Q1 2014$27,620,000
+36.1%
324,869
+28.7%
0.14%
+34.3%
Q4 2013$20,291,000
+7.2%
252,437
+2.3%
0.10%
+6.2%
Q3 2013$18,935,000
+3.6%
246,835
-4.5%
0.10%
-4.0%
Q2 2013$18,273,000258,4230.10%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders